A new Yale study reveals why colorectal cancer is rising in people under 50. Researchers found that early-onset tumours show distinct biology, including unique metabolic changes, low PD-L1 levels and reduced dopamine-related metabolites. These findings may explain the rapid surge in young patients and could lead to earlier detection and more targeted treatments in the future.